Sarah Cannon Research Institute

During this season of gratitude and #LungCancerAwarenessMonth, we’re grateful for Robert Jotte, M.D., Ph.D., Disease Chair and Executive Committee Member, Lung Cancer Research Executive Committee, Sarah Cannon Research Institute; Rocky Mountain Cancer Centers, and the research he contributes to which provides more patient treatment options. Advancements and clinical trials truly are a collaborative effort across researchers, doctors, and patients. Read his article below to learn how each area plays a role in improving patient care. #CancerResearch #LungCancer #PatientCare

We are pleased to announce that Dr. Krish Patel has been appointed as the Director of Lymphoma Research at SCRI! ? In his new role, Dr. Patel will lead our lymphoma research program and will practice at SCRI Oncology Partners in Nashville, starting mid-November. His appointment is a exciting step in strengthening our capacity to advance lymphoma clinical trials and enhancing patient care within our research network. ? Join us in welcoming Dr. Patel to SCRI! ? ?? Read the full press release: https://lnkd.in/gb2T3niJ ? #CancerResearch #Lymphoma #Oncology #ClinicalTrials #SCRI ?

Join us tomorrow for AIM’s patient-focused Living With Melanoma symposium! We are excited to announce that our very own melanoma expert, Dr. Meredith McKean, Director, Melanoma & Skin Cancer Research; Executive Chair, Bridge Research Executive Committee & Melanoma Research Executive Committee, SCRI Oncology Partners, will be a featured speaker. This symposium is a crucial event for patients and healthcare professionals to gather, share knowledge, experiences, and innovative ideas. These symposiums are instrumental in empowering patients with vital information about their condition, treatment options, and available support networks. Don’t miss this chance to learn from leading experts and connect with the melanoma community! Register now! https://bit.ly/3O3D55z #MelanomaSymposium #LivingWithMelanoma #PatientEmpowerment #CancerResearch #MelanomaAwareness

Erika Hamilton, MD, Chair, Breast Executive Committee Director, Breast Cancer Research Program Sarah Cannon Research Institute, shares her insights into one of the newest cancer therapies making waves in treatment: endocrine therapy. ? These studies suggest that novel therapies may help delay the need for treatments with greater toxicities. Learn more from?Targeted Oncology here:?https://lnkd.in/egbwB-Ft ? #BreastCancer #Endocrine #CancerInnovation

We are excited to share the latest installment in our Rediscover SCRI Recruiting Series, spotlighting the incredible journey of our colleague, Penny. ? Penny's story with Sarah Cannon Research Institute (SCRI) began in September 2009. From her initial role supporting studies—ranging from submitting letters of intent to the FDA, managing studies, to study closures and archives—Penny has always been a dedicated member of our team. ? After a two-year stint as a Research Study Coordinator at a local hospital, Penny rejoined SCRI in June 2015. Her diverse research background and site perspective have been invaluable to our Quality Assurance team supporting Sarah Cannon Development Innovations. ? Penny says, "The colleagues I have worked with at Sarah Cannon put participant safety first. I feel blessed to be a part of a team that is professional and cognizant of the importance of participant safety, communication, and documentation." ? Penny’s commitment to participant safety and her diverse research experience embody the core values that make SCRI a leader in healthcare innovation. We are grateful to have her as part of our team and look forward to her continued contributions. ? Join us in celebrating Penny’s inspiring journey and dedication to research excellence! ?? ? Are you inspired by Penny's story? Explore exciting career opportunities with SCRI and become part of a team that values excellence and innovation. Visit our careers page to learn more: https://lnkd.in/e5hFN2ri ? #SCRI #RediscoverSCRI #ResearchExcellence #HealthcareInnovation #TeamSpotlight #ParticipantSafety #PatientCare

October is Patient-Centered Care Awareness Month. At Sarah Cannon Research Institute, patients are at the heart of everything we do. This month, we’re highlighting a few of the many voices of our dedicated physicians who play a crucial role in ensuring patients not only have access to cutting-edge advancements but also receive the personalized care they need. Swipe through to hear from Dr. Mark Fleming, Cesar Perez M.D., Erika Hamilton, MD, Ishwaria Subbiah, MD, MS, FASCO, and Dr. Charles Anderson, on why clinical trials are essential to delivering patient-centered care. #PatientCare #ClinicalTrials

We’ve seen promising advancements in breast cancer treatment over the past decade, but there’s still more work to be done. Erika Hamilton, MD, Chair, Breast Executive Committee Director, Breast Cancer Research Program Sarah Cannon Research Institute shares her insights into the latest trends she’s seeing and the implications for women. ? Watch her interview with Contemporary OB/GYN below.

We are thrilled to welcome Dr. Deepak Bhamidipati as our new Assistant Director of Drug Development at Sarah Cannon Research Institute (SCRI)! Dr. Bhamidipati will also serve as a medical oncologist at SCRI Oncology Partners starting October 22. In his new role, Dr. Bhamidipati will work closely with Vivek Subbiah, MD, our Chief of Early-Phase Drug Development, to further enhance our early-phase drug development program in Nashville. Join us in welcoming Dr. Bhamidipati to SCRI! ?? #SCRI #DrugDevelopment #Oncology? https://lnkd.in/gZcJQj7A

Remember Jimi, one of our amazing CRISPR patients who was featured across many national media outlets? Not only did he reach new healthcare heights with the CRISPR therapy, but he recently reached new heights by summiting Mount Kilimanjaro in September! Jimi, a 39-year-old business owner from Atlanta, is the world’s first patient with sickle cell disease (SCD) to reach the summit of Kilimanjaro. Patients with SCD are at serious risk of complications and death in low-oxygen environments; doctors advise against entering an elevation of 10,000+ feet. Jimi, now functionally cured, summited Kilimanjaro at 19,341 feet! Join us in congratulating Jimi on this amazing accomplishment! #CRISPR #ClinicalTrials #SickleCellDisease #PatientStory #Inspiration #MountKilimanjaro #HealthJourney

We are excited to announce our partnership with BostonGene to integrate their molecular testing and informatics platforms into our network. This collaboration is set to validate novel biomarkers using BostonGene’s AI-powered multiomics platform in real-world cancer populations, enhancing our personalized oncology care. ?? Learn more: https://lnkd.in/gAtv8649 #Oncology